Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Observes Safety of Clozapine Treatment in Bipolar Disorder

Records side effects in adults with bipolar disorder taking clozapine.

Plain-language title generated from the registry record
Registry title: Observation of Clozapine Treatment Safety in Bipolar Disorder.

Key facts

Where
Gdansk, PolandSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT06011460, who can take part

Where in Poland

  • Department of Psychiatry, Medical University of GdańskGdansk, PolandNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Medical University of Gdansk
Trial code
NCT06011460
Record updated
25 August 2023
Original description
The purpose of the registry is to record incidence of adverse events during treatment with clozapine in patients suffering from bipolar disorder.Read full original descriptionShow less

Observation of Clozapine Treatment Safety in Bipolar Disorder.

The purpose of the registry is to record incidence of adverse events during treatment with clozapine in patients suffering from bipolar disorder.

Inclusion: Diagnosis of treatment-resistant depressive episode in the course of bipolar disorder according to DSM-5; Age from 18 to 65 years old.

Exclusion: Patients unable to give fully written informed consent; Patients unable to comply with the requirements.

ClinicalTrials.gov NCT06011460